Tenax Therapeutics Inc (TENX)

[7777777]

After a tumultuous year that featured the dismissal of its CEO, drug-development company Oxygen Biotherapeutics is starting 2012 in its best financial shape in years.

The small, publicly traded Morrisville company turned a financial corner at the end of last year when it sold $7.5 million in preferred stock and warrants to institutional investors. The company received $3.5 million in December, with the second installment expected midyear.

In the past, Oxygen Bio has raised money that would carry it forward for about six months, but this was a richer deal.

Read more here: http://www.newsobserver.com/2012/01/25/1804303/funds-breathe-new-life-into-oxygen.html#storylink=cpy